“WE GIVE VIRUS-LIKE PARTICLES AND CREATE ANTIBODY”
Health Sciences University Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital Chest Diseases Specialist Assoc. Dr. Halit Çınarka explained the details of my VLP transition.
Stating that the VLP vaccine is a new technology, Çınarka said, “We give virus-like particles and create antibodies in the patient. Thus, we can say that when the virus comes to us, we can say that it is a technology that will ensure that you do not get sick, thanks to the antibody covering the places where the cells will adhere.”